Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study

Clinical trial NCT07189793 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07189793
Sponsor: First Affiliated Hospital of Wenzhou Medical University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Urinary Bladder Neoplasms Carcinoma, Transitional Cell Carcinoma in Situ of Bladder Non-Muscle-Invasive Bladder Cancer

Start date: 2025-10-01
Primary completion: 2027-10-01
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.